Rhon-klinikum Ag · XETR:RHK

Rhon-klinikum — FY2017 Earnings Presentation

9 slides from Rhon-klinikum's earnings presentation, Feb 23, 2018

  1. Slide 1: Preliminary Results for FY 2017

    Preliminary Results for FY 2017 23 February 2018 Stephan Holzinger, CEO RHÖN-KLINIKUM AG - Preliminary Results of 2017 - as of February 23, 2018

  2. Slide 2: Disclaimer

    Disclaimer  This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose

  3. Slide 3: Highlights FY 2017

    Highlights FY 2017  New agreement on separate accounting signed  Final contract closing with the State of Hesse accomplished in Q4 2017  Already approved in state budget by the Hesse parliament in Q1 2018  Validation by auditor to be finalized in 2018  Transforming “Campus Concept” through digi

  4. Slide 4: Preliminary Results FY 2017

    Preliminary Results FY 2017 * Cases Revenues  Volume growth -1.2% +3.0% 1,211 (DRG case-mix-points) 1,176  +2.8% more inpatient and outpatient cases  Total number of treated patients 836,387 FY 2016 FY 2017 in million € Earnings & Cash UKGM C  EBITDA € 98m  FY 2017 revenues +2.9% **  Net Profi

  5. Slide 5: Strategic Focus: Campus Concept and eHealth as Key Projects

    Strategic Focus Campus Concept and eHealth as Key Projects „NEW RHÖN“ Business Approach CAMPUS Existing Portfolio CONCEPT High-quality integrated care for rural areas with Bad Neustadt UKGM a first-of-its-kind prototype opening at our Bad Neustadt site at Bad Berka Frankfurt (Oder) the turn of 2018/

  6. Slide 6: Outlook 2018

    Outlook 2018 Assumptions & Key Drivers Organic growth Other Impacts Inflation on One-Off Effects +3.0% to 3.5% p.a. on Top Line input prices on EBITDA  Average DRG prices  “Spinraza” effect with  Wages  Separate accounting +2.7% approx. +€ 20m +2.0 % to +3.0% +€ 20m  Average DRG volumes  IFRS

  7. Slide 7: Financial Calendar for FY 2018

    Appendix Financial Calendar for FY 2018  23 February 2018 Preliminary results for financial year 2017 Conference call  29 March 2018 Publication of annual financial report 2017 Press conference  4 May 2018 Publication of interim report for the quarter ending 31 March 2018  6 June 2018 Annual Gen

  8. Slide 8: Price Regulation in 2018 at a Glance

    Appendix Price Regulation in 2018 at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level  Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) 1 DRG inflation in 2018: +2.97%

  9. Slide 9: Shareholder Structure

    Appendix Shareholder base Shareholder Structure as of 31 December 2017, according to the most recent notifications of voting rights at that time 25.1% Asklepios 26.7% 1) 29.9% Free Float 70.1% 3.2% Strategic Landeskrankenhilfe Investors 5.4% 25.0% 2) Ingeborg Münch B. Braun 14.6% Eugen Münch/HCM SE

Rhön-Klinikum — FY2017 Earnings Presentation on 6ix